Sibionics
Changsha, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A medical device company developing continuous glucose monitors and digital diabetes management platforms.
Metabolic Disease
Technology Platform
Proprietary biosensor and transmitter technology for continuous glucose monitoring, integrated with a digital health app.
Opportunities
Huge addressable market in China's large diabetic population seeking affordable, high-tech management solutions.
Risk Factors
Intense competition and potential pricing pressure, alongside the need for continuous technological innovation.
Competitive Landscape
Competes in the fast-growing but crowded CGM market against large international leaders and other domestic Chinese startups.